Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Sharon Kleyne Urges Eye Examinations for Cataracts
  • USA - English


News provided by

Bio-Logic Aqua® Research – Water Life Science® -Rogue Media

Jul 06, 2016, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Bio-Logic Aqua® Research Water Life Science® Founder Sharon Kleyne
Bio-Logic Aqua® Research Water Life Science® Founder Sharon Kleyne

Grants Pass, OR (PRWEB) July 06, 2016 -- Sharon Kleyne, founder of Bio-Logic Aqua® Research Water Life Science® responds to recent articles and statistics regarding blindness and cataracts, and urges examinations to identify eye health concerns.

A recent article from the NM Department of Health cites statistics from the patient advocate group Prevent Blindness regarding cataracts. "Prevent Blindness estimates the current number of people in the United States with cataracts will increase from more than 25.7 million to an estimated 38.5 million by 2032, and then to 45.6 million by the year 2050." (http://www.lcsun-news.com/story/life/wellness/2016/06/15/nm-dept-health-cataract-symptoms-look/85668952/)

According to the World Health Organization, 285 million people are visually impaired, with almost 40 million blind, yet 80 percent of visual impairments can be prevented or cured.

Sharon Kleyne, Bio-Logic Aqua® Research Center founder, creator of Nature’s Tears EyeMist and host of The Sharon Kleyne Hour Radio Talk Show (http://www.voiceamerica.com/show/2207/the-sharon-kleyne-hour) considers these statistics and urges everyone to have their eyes examined for cataracts. She also encourages everyone to educate themselves about this serious vision threat.

Cataracts occur, especially in people over the age of 40, when protein in the eye’s natural lens (between the iris and the pupil) clumps together and creates a cloudy condition. Not only is it the main cause of blindness in the world, according to Prevent Blindness America (PBA), there are more global cases of cataracts than there are of diabetic retinopathy, glaucoma and macular degeneration combined. After age 40, cataracts affect more than 22 million Americans, and PBA projects that by 2020—just four years from now—more than 30 million Americans will suffer from cataracts. Symptoms may include blurred vision—as if you were looking through a cloudy glass—dull colors, glaring headlights when you drive at night, or sunlight that seems so bright it hurts.

The three known types of cataracts include: subcapsular cataract, which occurs at the back of the lens (people with diabetes and people taking large doses of steroids have the greatest risk), nuclear cataract, which takes shape deep in the lens’s nucleus and is most often associated with aging and cortical cataract, which occurs in the lens cortex and is identified by white opacities in the shape of wedges that seem to begin in the periphery of the lens and work inward to the center in a spoke-like design.

Kleyne, for decades a leading voice in eye and skin care using water and rehydration, encourages every person on earth to take responsibility for their own eye care before it is too late. “Eyes and skin are constantly assaulted,” Kleyne says, “by dehydration and depletion of earth’s water vapor due to pollution and climate change. Dry Eye Syndrome, allergies and respiratory conditions lead directly to cataracts and blindness.”

A unique, preventative safeguard against cataracts can be found in Bio-Logic Aqua® Research Water Life Science®’s Nature’s Tears EyeMist, the personal hand-held humidifying device emitting a pure, pH balanced, 100% water mist for rehydrating eyes. Nature’s Tears EyeMist is endorsed by more than 22,000 ophthalmologists and optometrists nationwide and was successfully test-marketed in more than 70,000 outlets.

The new research at Bio-Logic Aqua Research® Water Life Science® suggests that a future in which the affliction of cataracts is greatly diminished is on the horizon. Preventative measures such as regularly using Nature’s Tears EyeMist will make all the difference.

“You only have two eyes,” Kleyne reminds us, “and they are almost completely made of water. If you want to see clearly, and who doesn’t, you must be hydrated! Drink at least 8 glasses of water every day and mist your eyes with our pure, culture grade Trade Secret fresh water.”

©2016 Bio-Logic Aqua® Research Water Life Science®. All rights reserved.

Mikaylah Roggasch, Bio-Logic Aqua® Research – Water Life Science® -Rogue Media, http://www.biologicaqua.com, +1 (800) 367-6478, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.